Cargando…
A proposal for staging COVID‐19 coagulopathy
Coronavirus disease 2019 (COVID‐19) is associated with significant hypercoagulability. However, despite prophylactic anticoagulation, critically ill patients with this condition develop thromboses. This forum discusses the lungs as the epicenter for the hemostatic issues, puts forward a proposal for...
Autores principales: | Thachil, Jecko, Cushman, Mary, Srivastava, Alok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272892/ https://www.ncbi.nlm.nih.gov/pubmed/32685880 http://dx.doi.org/10.1002/rth2.12372 |
Ejemplares similares
-
Proposal of the Definition for COVID-19-Associated Coagulopathy
por: Iba, Toshiaki, et al.
Publicado: (2021) -
Lessons learnt from COVID‐19 coagulopathy
por: Thachil, Jecko
Publicado: (2021) -
The unique characteristics of COVID-19 coagulopathy
por: Iba, Toshiaki, et al.
Publicado: (2020) -
ISTH interim guidance on recognition and management of coagulopathy in COVID‐19
por: Thachil, Jecko, et al.
Publicado: (2020) -
The versatile heparin in COVID‐19
por: Thachil, Jecko
Publicado: (2020)